|
HS Code |
919349 |
| Product Name | (R)-1-N-Boc-Beta-Proline |
| Cas Number | 110267-43-7 |
| Molecular Formula | C10H17NO4 |
| Molecular Weight | 215.25 |
| Appearance | White to off-white solid |
| Purity | Typically >98% |
| Optical Purity | Typically >98% ee |
| Melting Point | 80-84°C |
| Storage Temperature | 2-8°C |
| Solubility | Soluble in organic solvents (e.g., DCM, ethanol) |
| Smiles | CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O |
| Inchi | InChI=1S/C10H17NO4/c1-10(2,3)15-9(14)11-7-4-5-8(6-7)12/h7-8H,4-6H2,1-3H3,(H,11,14)(H,12,13)/t8-/m1/s1 |
| Chirality | R-configuration |
| Protecting Group | Boc (tert-butoxycarbonyl) |
| Use | Chiral intermediate for peptide synthesis |
As an accredited (R)-1-N-Boc-Beta-Proline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for (R)-1-N-Boc-Beta-Proline, 5 grams, is a sealed amber glass vial with a tamper-evident screw cap. |
| Shipping | Shipping for (R)-1-N-Boc-Beta-Proline is conducted in secure, leak-proof containers under ambient conditions, complying with all relevant chemical transport regulations. The product is typically packaged with proper labeling and documentation to ensure safety during transit. Expedited and international shipping options are available, subject to destination-specific chemical shipping guidelines. |
| Storage | (R)-1-N-Boc-Beta-Proline should be stored in a tightly sealed container, protected from moisture and light, at 2–8°C (refrigerator temperature). The storage area should be dry and well-ventilated, away from incompatible substances such as strong acids or oxidizers. Proper labeling and access control are recommended to maintain chemical integrity and safety. |
Applications of (R)-1-N-Boc-Beta-Proline in Industrial ManufacturingAs an original producer, we supply (R)-1-N-Boc-Beta-Proline to global manufacturing sectors requiring precise enantiopure building blocks for advanced synthesis. Below we detail core industrial applications, process integration points, and relevant compliance frameworks based on actual downstream production practice. 1. Chiral Intermediate in Active Pharmaceutical Ingredient (API) SynthesisPharmaceutical manufacturers use (R)-1-N-Boc-Beta-Proline as a stereoselective intermediate to construct beta-proline-derived APIs. Its protected structure enables direct incorporation into chiral centers in synthesis pathways, minimizing racemization risks during multi-step production. Application typically includes peptide drugs and specific alkaloid analogues targeting therapeutic modulation, where enantiopurity and reproducibility ensure clinical safety and regulatory acceptance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Stereoselective Catalyst Precursor for Asymmetric SynthesisProducers of fine chemicals and API intermediates utilize (R)-1-N-Boc-Beta-Proline to generate chiral ligands for catalytic asymmetric synthesis. The material provides a foundation for metal-ligand complexes driving stereocontrolled addition, reduction, or cyclization operations. This ensures consistent stereoisomer yields in key intermediates without chiral contamination, especially in large-scale batch or continuous processes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Protected Beta-Amino Acid Building Block for Peptide SynthesisOligopeptide and synthetic protein manufacturers deploy (R)-1-N-Boc-Beta-Proline in solution-phase and solid-phase peptide synthesis. Its Boc protection guards the amine during repetitive coupling cycles, supporting high sequence fidelity and reducing risk of racemization. Producers incorporate it into specialized pharmaceutical peptides, cosmetic peptides, and biological research reagents where custom beta-amino acid positions affect target conformation or biostability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chiral Reference Standard Preparation for Analytical LaboratoriesChemical reference laboratories and pharmaceutical QC divisions rely on (R)-1-N-Boc-Beta-Proline to prepare certified reference materials (CRMs) for analytical method validation. The well-defined stereochemistry supports the quantification of enantiomeric excess and calibration of chiral separation techniques, including HPLC, SFC, and NMR, crucial for regulated batch release and method transfer in pharmaceutical and fine chemical environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (R)-1-N-Boc-Beta-Proline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Work in a chemical plant looks very different from an office with spreadsheets and presentations. With (R)-1-N-Boc-Beta-Proline, everything begins on the production floor—rows of glass reactors, exhaust fans humming, operators checking digital instruments, and the subtle aroma of organic intermediates. We’ve spent years perfecting the routes that allow us to produce this amino acid derivative, refining purification steps beyond what many catalogues offer. (R)-1-N-Boc-Beta-Proline is now a cornerstone in many chiral synthesis pipelines because its purity, reactivity, and enantiomeric excess stay consistent from batch to batch.
The appeal of this product is not only within its chemical structure—N-Boc protection attached to the β-carbon of proline, in the R absolute configuration—it’s also the way modern industrial synthesis rolls out a scalable, high-yield route. Lab-scale chemistry rarely faces the setbacks that appear in scale-up: occasional over-reduction, problems with crystallization, or N-deprotection under ambient moisture. Our technical team talks about these realities not in hypotheticals, but from confronting failed crystallizations at two in the morning and watching purity on HPLC drift when solvents accumulate water. Every percentage point of enantiopurity makes the difference for chiral drugs, for asymmetric catalysis, and for peptide manufacturing down the line. Over time, our feedback loop—chemists working with quality control, process engineers troubleshooting—cuts out sources of racemization and obviates guesswork.
Whenever you walk between drums, the differences between a catalog-grade and pharmaceutical-ready beta-proline become clear. Our process delivers (R)-1-N-Boc-Beta-Proline with ≥99% enantiomeric excess, confirmed batchwise by chiral HPLC. The material appears as a white crystalline powder, flows smoothly, and resists caking even through months in storage at 2–8°C. We control moisture tightly: Karl Fischer titration confirms water content below 0.5% w/w, sidestepping reactivity surprises in coupling reactions or resin loading. Most lots pass purity at ≥99% by HPLC, but we monitor for residual solvents and known-process impurities—if trace toluene or methyl tert-butyl ether pokes above 0.3%, we batch-hold and investigate.
Particle size distribution shapes how our customers use the material. Solid dispensing in automated peptide synthesizers works better with narrow ranges, while hand-weighing in process development sees fewer static-charged clouds and less material loss. We recalibrate sieving every few weeks to match customer feedback, not only relying on measurements but also the real operator’s judgment: does the powder pour easily, does it hang in the bottle’s neck, or tumble out on the first try? These details seem minor until a reaction stalls from poor mixing or creates problems downstream with caked intermediates.
Customers talk to us about (R)-1-N-Boc-Beta-Proline as a building block for peptide drugs, active pharmaceutical ingredients, and chiral auxiliaries. Scientists from large pharma and contract manufacturing organizations know the standard L-proline and its N-Boc derivatives won’t substitute: the beta-substitution and R configuration shift reactivity. Peptides using β-amino acids display altered secondary structures, enhanced metabolic stability, and distinct pharmacokinetic properties, none of which L-proline or standard alpha amino acids can provide. The N-Boc group shields the amine during coupling, reduces racemization, and improves solubility in common organic solvents, opening doors for solid-phase and solution-phase synthesis strategies.
If you walk through our kilogram plant, operators discuss reorder requests for high-purity beta-prolines. Some customers need hundreds of grams for library synthesis, others take multi-kilogram drums for full-GMP manufacture. Our team shares one philosophy: no tolerance for cross-contamination, moisture ingress, or unexpected chiral drift. Every batch passes through both chiral and achiral purity testing, with retests on reference lots maintained in year-long quality retainers.
By maintaining internal consistency—beyond external requirements—we eliminate surprises for customers. When feedback triggers a process improvement (like slower Boc introduction or alternate basic scavengers to limit racemization), our documentation and training incorporate it for every operator, not by rote but from deep process understanding. In the rush for speed to launch or for regulatory filings, this thoroughness guarantees that “same product, different lot” actually means an identical experience from one batch to the next.
As a chemical manufacturer, the differences show in ways that paperwork won’t capture. Consider standard L-proline: two key points set beta-proline apart. L-proline, a secondary amine and alpha-amino acid, features a five-membered ring connected at the alpha-carbon. In (R)-1-N-Boc-beta-Proline, substitution on the beta position transforms its chemistry. The core ring structure stretches the backbone and alters dihedral angles in peptides, giving rise to helical, sheet, or turn motifs rare for native proteins. In one customer's case, swapping in beta-proline shifted the biological half-life of a preclinical peptide from thirty minutes to six hours—a visible transformation in animal studies, not theory.
The N-Boc group acts as more than a simple protecting group. When working up coupling reactions, chemists notice improved solubility, easier purification of intermediates, and less by-product formation. In solid-phase synthesis, the powder’s properties translate into higher yields, easier cleaning, and consistent resin loading. Small changes in physical form can create large practical differences—powder that clumps on a humid day versus free-flowing material saves hours on cleanup and tens of grams in overall yield.
We receive requests for other protected prolines: N-Cbz, Fmoc, or unprotected beta-prolines. Fmoc variants dominate in automated solid-phase peptide synthesis, while Cbz types appeal to hydrogenolysis users. Still, Boc-protected beta-proline remains the most versatile, balancing stability during storage with ease of deprotection under mild acidic conditions.
Research chemists often order a bottle from a major catalogue expecting sameness, but scale-up exposes variation. On our end, controlling variables requires both routine and innovation—reaction temperatures adjusted by a fraction, drying carried out under deeper vacuum, and analytical rechecks spanning HPLC, TLC, and NMR. It’s not just about meeting an assay number, but about the feeling for the material—fineness, color, aroma, ease of transfer.
Our team has debated shifting to continuous production or batch-automation. In practice, the subtlety of process interruptions, and the need to deal with rare failures, keeps batch-based approaches in place for this intermediate. Continuous flow can increase throughput, but when something veers off-spec—an acid addition misfires, or Boc anhydride lags in—batchwise corrections can save an entire campaign. Scale brings its own traps: not just process control, but stock management, packaging, and reliable cold-chain logistics count just as much as synthetic flair.
Pharma partners see (R)-1-N-Boc-beta-Proline as more than a building block. The route from intermediate to active drug molecule traverses dozens of steps: each with their own foul-ups, constraints, and compliance paperwork. Whether supporting preclinical research or commercial API manufacture, we’ve produced this compound at scales from 100 grams for method validation up to multi-ton shipments for high-volume peptide APIs. A few clients use it as a key part of single-domain antibody modifications; others run polymer chemistry projects that use beta-amino acids to shift material properties from brittle to flexible.
Working side by side with these teams, we see expectations evolve. Regulatory submissions require not just a certificate of analysis, but full traceability: where each drum originated, how it was transported, what quality checks were met in each warehouse. We field regular audits, and every process change appears in quality agreements. Documentation—the tangles of batch cards, deviation reports, and inspection findings—supports the technical backbone of synthesis. No customer wants to explain a failed synthesis that tracks back to fluctuating enantiomeric excess due to inconsistent sourcing.
GMP doesn’t only mean batch record-keeping or environmental monitoring, but a persistent mindset. Our operators wear clean suits, walk airlocks, and sweep floors not because it reads right in procedures, but because missed lint and solvent puddles have tripped production in the past. We push for zero cross-contamination. Dedicated glassware and reactors run beta-prolines, while alternate lines prepare unrelated products. While many industry standards call for low levels of cross-contamination, we hold to internal thresholds that often overshoot regulatory minimums.
Feedback from customers shapes our process improvement cycles. Sometimes a process chemist flags a change in crystal habit or a little more “stickiness” in delivered lots. These subjective details can precede analytical differences, so our lab team responds with targeted particle size analysis, dynamic vapor sorption, or even re-examination of drying times. Chasing unexpected variability may take days of operator time, but this persistence narrows quality gaps and builds trust over years, not just orders.
As environmental concerns sharpen across the chemical industry, every synthesis stage receives fresh scrutiny: solvents, reagents, waste management, and energy use. Beta-proline production, like most amino acid derivatives, generates some aqueous and organic waste. Our engineering team has pivoted from legacy methods—acetonitrile-heavy extractions, dichloromethane-based crystallizations—to greener options whenever yields and purity stay high. Where Boc anhydride and tertiary amines once dominated the waste stream, more selective addition and workup protocols now cut down on byproducts.
We work with regional waste processors who understand specialty chemical streams, not just bulk pharma. By-products, especially acids and organic salts, receive specialized handling and documentation, fitting the higher standards expected by global pharmaceutical buyers. Solvent recycling, energy recovery in drying processes, and waste heat integration make incremental but meaningful cuts in carbon footprint. These decisions grow the company’s operational efficiency, but they also align with how modern customers want to de-risk supply chains—knowing their partners support more than just cost and yield.
During recent global supply chain shocks, customers asked us to secure continuity for their critical beta-proline inputs. The challenge forced real-time logistics planning, multiple vetted suppliers for every primary starting material, and our internal stockpiling. Plant and QA teams committed extra hours for off-cycle manufacturing, ensuring that key API and peptide campaigns did not halt for our end users.
The challenge spoke to the necessity for trust in supplier relationships. On paper, most GMP suppliers offer similar products, yet customers tell us about weeks-long back-orders and silent interruptions. Our focus on raw material sourcing, robust process scheduling, and in-house analytical testing provided a layer of resilience that third-party traders or brokers rarely match. Commitment to both documentation and transparency underlines every customer conversation and site tour.
Chemists and engineers in manufacturing share a perspective that traders, resellers, or brokers might miss. Chemical synthesis is unpredictable enough without additional layers of indirection. Each vessel, each filtration, and every drying step introduces risks that multiply with scale. A manufacturer’s advantage becomes clearest in the problem-solving: a filtration halt, a temperature spike, or an unexplained color change. Every line chemist can recount equipment issues, process deviations, and days lost to what look like trivial variables—a loose o-ring, an aging stirrer bearing, humidity reach into a supposedly airtight bag.
We deal with these challenges directly. Years in the plant teach vigilance in process monitoring, proactive maintenance, material compatibility, and the art of adaptation. Beta-proline’s value for our customers comes not only from our synthetic route, but also from consistency batch-to-batch, communication about lead times and deviations, and willingness to troubleshoot alongside partners.
Open dialogue with process development scientists and procurement specialists drives concrete changes to every step of our operation. Whether a batch’s crystal habit shifts slightly or a downstream reaction stalls, the customer’s lived experience flows directly into process and quality reviews. We know from hard-won experience that even a one-degree shift in drying temperatures or a change in packaging material can disrupt solubility, transfer losses, or reactivity. This direct relationship bypasses the slow feedback loops of third-party channels, letting us fix issues before they grow into recurring problems.
Over the past few years, the most productive improvements began as real conversations about synthesis headaches, not abstract improvement initiatives. Examples include changing the bottle anti-static liners after seeing powder cling in dry winters, recalibrating blending cycles for narrow crystal size distributions, and eliminating paper dust from packaging. Changing an organic base to one less odorous in the synthesis, even at the cost of slightly longer reaction times, responded directly to customer input on workplace safety and odor control.
Innovation in chemical manufacturing has less to do with chasing the latest buzzwords or automation for its own sake, and more with hands-on iteration. Our investments in analytical technology—chiral HPLC, NMR, mass spectrometry—pair with traditional skills: careful hands in the crystallization bay, visual checks during drying, trust between shift operators. Changes begin with pilot scale, scale to production after validation, and finally cement into routine manufacturing only after repeated success, not just one lucky trial.
Some innovations brought immense value, such as tighter nitrogen blanketing to suppress racemization or shifting to new solid handling systems for bagless transfer. Others required backtracking or months-long adjustment, like fine-tuning Boc introduction times, only to discover older parameters already hit the ideal compromise of yield and purity. Innovation coexists with humility—each attempt at improvement rides alongside the knowledge that process drift, human error, or unusual batches happen even in the best-run plants.
Global regulators now scrutinize not only the finished material but the entire manufacturing chain. We’ve fielded audits from health authorities in multiple regions, tuning our controls to changing standards. Advanced analytical controls catch deviations in enantiopurity, fines, residual solvents, and impurities, delivering certainty before product leaves the plant. Digital traceability and updated training help create both accountability and confidence—not as tick-box requirements, but as supports for an operation where real people design, make, and ship beta-proline to real customers with real deadlines.
Every gram of (R)-1-N-Boc-beta-Proline shipped out the door carries the story of technicians who handled, dried, weighed, and tested it with careful competence. Our years making this building block show that the core value lies in the intersection of technical skill, robust processes, transparency, and continuous customer feedback. Customers benefit from a resilient supply, batch-to-batch consistency, and a real-time partnership for troubleshooting—all the outcomes that only a working manufacturer’s culture produces. For (R)-1-N-Boc-beta-Proline, the science walks hand in hand with operator knowledge and a shared understanding of what reliability means at scale.